February 24, 2026
Novo Nordisk to Cut Ozempic, Wegovy Prices Up to 50 Percent in US
Price cuts to help people living with obesity and Type 2 diabetes will take effect on Jan. 1, 2027, company says.
TL;DR
- Novo Nordisk will decrease the list price of Ozempic and Wegovy by up to 50% starting January 1, 2027.
- The new price for specific dosages of Wegovy, Ozempic, and Rybelsus will be $675.
- This reduction is intended to improve access for over 100 million people with obesity and over 35 million with Type 2 diabetes in the U.S.
Continue reading the original article